Ethnopharmacological relevance: The scientific study of natural products traditionally used in anticancer preparations has yielded several therapeutically relevant compounds. One of these traditional preparations with potentially beneficial properties is aqueous extracts of Sutherlandia frutescens, a shrub indigenous to the Western Cape region of South Africa. 
Introduction
Cancer is one of the leading health risks in modern society and several avenues of research into possible alternative therapies are currently being pursued. One of the areas of cancer research which has made significant contributions towards improved cancer treatments is ethnopharmacology. The scientific study of natural products which have traditionally been used as antiproliferative preparations has yielded several compounds clinically relevant to 3 modern antiproliferative therapy (Balunas and Kinghorn, 2005; da Rocha et al., 2001 ) and phytochemical therapy continues to be an area of active research (Neergheen et al., 2010) .
One of the traditional preparations which show promise is aqueous extracts of Sutherlandia frutescens (tribe Galegeae, Fabaceae), a shrub indigenous to South Africa, Lesotho, southern Namibia and south-eastern Botswana (van Wyk and Albrecht, 2008) . It is traditionally used as a tea (aqueous extract) to remedy a variety of ailments ranging from cancer and diabetes to intestinal disease (Chinkwo, 2005; van Wyk and Gericke, 2000) , and recently to improve the overall health of human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS) patients (Klos et al., 2009; Brown et al., 2008; Harnett et al., 2005; Grandi et al., 2005; Morris, 2001) . S. frutescens has been commercially cultivated on small scale since 1990 (van Wyk and Albrecht, 2008) . More recently, Phyto Nova (Pty) Ltd (Cape Town, South Africa) started large scale cultivation and export of S. frutescens tablets, as well as a gel-based S. frutescens product for external anti-inflammatory and analgesic use (http://www.phyto-nova.co.za/). (water, ethanol, methanol, acetone , methylene dichloride) have demonstrated antiproliferative (Chinkwo, 2005) , anti-HIV (Harnett et al., 2005) , antidiabetic (Chadwick et al., 2007) , anti-inflammatory, antibacterial (Katerere and Eloff, 2005) , analgesic, anticonvulsant and antithrombotic activities. However, the molecular mechanisms of action of S. frutescens are still poorly characterized. Research into the chemical constitution of the plant has shown that S. frutescens contains large amounts of amino acids (notably L-arginine and L-canavanine), pinitol, flavonol glycosides and triterpenoid saponins (Moshe et. al., 1998) (van Wyk and Albrecht, 2008) (Shaik et al., 2010) . L-canavanine replaces the structurally related amino acid L-arginine during protein synthesis, leading to non-functional proteins. L-arginine is a direct precursor of nitric oxide which has cytostatic 4 and pro-apoptotic effects (Pervin et al., 2008) . Pinitol is metabolised to D-chiro-inositol (3-0-methyl-1,2,4-cis-3,5,6-trans-hexahydroxycyclohexanol) which has insulin-like activity, affecting glucose transport. Flavonol glycosides inhibit cytochrome P450 enzymes responsible for lipid and steroid catalysis (Androutsopoulos et al., 2010) , while triterpenoid saponin metabolites exert cytotoxic effects on tumour cells (Chan, 2007) .It has been demonstrated in our laboratory that ethanolic extracts of S. frutescens induce an S-phase cell cycle arrest, apoptosis and autophagy in cultured breast adenocarcinoma cells (Stander et al., 2009 ). Chinkwo (2005) showed that apoptosis induction occurred as a result of flip-flop translocation of the membrane protein phosphatidylserine. It is suspected that ethanolic and aqueous extracts of S. frutescens have significantly different chemical constituents and would thus have different effects on the cellular physiology of both normal and transformed cells.
Extracts of S. frutescens
Furthermore, it has been suggested that a group of compounds, rather than a single active ingredient, is responsible for cytotoxic effects observed. Given the widespread traditional use and therapeutic potential of S. frutescens, further research into the exact mechanisms of the actions exerted by S. frutescens extracts is warranted. Thus, the aim of this study was to evaluate aqueous S. frutescens extracts for cancer research potential and to investigate and elucidate the signaling mechanisms involved in S. frutescens-induced cell death.
Materials and Methods

Cell lines
The MCF-7 cell line is derived from a pleural effusion of human breast adenocarcinoma which is commercially available from Highveld Biological Pty. (Ltd.) (Sandringham, SA).
The MCF-12A cell line is a non-tumorigenic epithelial cell line produced by long-term culture of normal mammary tissue. These cells were a gift from Prof. Parker (Department of Medical Biochemistry, University of Cape Town, Cape Town, SA).
Materials
Annexin V fluorescein isothiocyanate (FITC) staining kit was purchased from Miltenyi Biotec GmbH (Bergisch Gladbach, Germany). All other analytical grade reagents including cell culture media, sterile plates and flasks, actinomycin D, and the required reagents for crystal violet staining, haematoxylin and eosin staining, fluorescence microscopy and flow cytometric analyses, were obtained from either Sigma (St. Louis, USA) or Highveld Biological (Pty) Ltd. (Sandringham, South Africa).
S. frutescens
Dried leaves and small twigs of Sutherlandia frutescens (family: Fabaceae, subspecies Microphylla) were purchased from Ms. Eilleen Menne of Karoo Herbs (De Aar, South Africa). Specimens of S. frutescens were harvested and air-dried in the shade. Finely powdered S. frutescens leaves and twigs (0.5 g) were autoclaved and subsequently mixed to a final volume of 10ml with deionized boiling water and left overnight at room temperature.
The extract was centrifuged for 10min at 1000 × g (2500 rpm) and the supernatant was removed and filtered using a 0.2µm filter providing a stock solution extract of 0.05 g/ml as previously described (Stander et al., 2009 ).
Cell cultures
MCF-7 cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FCS), penicillin (100µg/l), streptomycin (100µg/l) and fungizone (250µg/l). MCF-12A cells were propagated in a medium containing a 1:1 mixture of DMEM and Ham's-F12 medium, 20 ng/ml epidermal growth factor, 100 ng/ml cholera toxin, 10µg/ml insulin and 500 ng/ml hydrocortisone, supplemented with 10% heat- Positive controls for apoptosis (actinomycin D) and autophagy (cells starved by culturing in 20% medium and 80% phosphate buffered saline) were included in each experiment and culture medium was changed before exposure.
Cell numbers -Crystal violet
Time-(24, 48, 72 hours) and dose-(0.5 -2.5mg/ml) dependent cell proliferation studies were conducted in order to determine the optimal exposure parameters for observation of the effects investigated in this study when comparing the results from the MCF-7 and MCF-12A cell lines. The initial reagent concentrations and times of exposure to S. frutescens extracts were selected to correlate with previous literature and studies conducted in our laboratory (Vorster et al., 2010; Stander et al., 2007; Chinkwo, 2005; Tai et al., 2004) . Cells were seeded at 5 000 cells per well in 96-well plates and incubated overnight at 37 o C in a humidified, 5% CO 2 environment to allow for attachment. Baseline values were determined before exposure to S. frutescens in order to quantify starting cell numbers. Cells were then exposed to the selected concentrations (0.5 -2.5mg/ml) of S. frutescens for 24, 48 and 72 hours, after which the experiment was terminated by removal of the medium and fixation of cells using 1% glutaraldehyde for 15 minutes. Cells were then stained for 30 minutes with 0.1% crystal violet. The 96-well plates were subsequently washed under slowly running tap water to remove excess stain and dried at room temperature overnight. Dried plates were exposed to 0.2% Triton X-100 at room temperature for 30 minutes to solubilize the crystal violet. After mixing, 100µl of the solution was transferred to a clean 96-well plate and the absorbance was read using an ELX-800 Universal Microplate Reader (Bio-Tek Instruments, Winooski, USA).
After half maximal growth inhibitory concentration (GI 50 ) values were calculated all subsequent experiments were conducted utilizing an exposure time of 48 hours at 1mg/ml S. frutescens, as these parameters presented the most significantly differential results in MCF-7 breast adenocarcinoma cells when compared to the non-tumorigenic MCF-12A breast epithelial cell line. The methodology utilized in this study has been standardized in our laboratory (Vorster et al., 2010) . Cells were seeded on heat-sterilized coverslips in 6-well plates at a density of 250 000 cells per well and allowed to attach overnight. Cells were subsequently exposed to 1mg/ml S. 
Flow cytometry
Flow cytometry was used to confirm the observed cell cycle disturbances, to investigate the intracellular events causing these aberrations and to measure indications of apoptosis. 
Statistical Analysis
Data from three independent experiments (each conducted with six replicates for crystal violet experiments) were analysed. Quantitative data was statistically analyzed for significance using the single factor (one-way) analysis of variance (ANOVA) model and a two-tailed, homoscedastic Student's t-test, with p-values < 0.05 being regarded as statistically significant. Means are presented in bar charts, with T-bars referring to standard deviations.
For flow cytometric data experiments were repeated thrice, 10 000 to 30 000 events were counted per sample and percentages were calculated by gating the supplier-provided isotypic control to < 1%.
Results
Crystal violet
A time-and dose-dependent decrease in cell numbers was observed in response to S.
frutescens exposure (Fig. 1) . A concentration of 1mg/ml S. frutescens and an exposure time of 48 hours were selected for further analysis, since these were the GI 50 parameters calculated for the MCF-7 breast adenocarcinoma cell line (51.79% of control), while the MCF-12A nontumorigenic cell line was significantly less affected (93.22% of control). The GI 50 value indicates the concentration inhibiting growth in 50% of cells in the sample. All subsequent studies were conducted using these experimental parameters. Data is shown in table 1. 
PlasDIC microscopy
PlasDIC microscopy revealed a decrease in cell numbers and density in S. frutescens-treated samples when compared to vehicle control samples in the MCF-7 cell line (100X magnification, data not shown), while only a slight increase in cytoplasmic vacuolization and some changes in nuclear morphology were observed in the MCF-12A cell line (Fig. 2) . The MCF-7 breast adenocarcinoma samples appear to be more susceptible to S. frutescens exposure, with an increase in the number of cell fragments and cells displaying apoptotic characteristics being observed. were observed in samples of both cell lines exposed to S. frutescens (Fig. 3) . 
Mitotic indices
Quantitative analyses revealed MCF-7 samples exposed to S. frutescens exhibiting a marked decrease in the percentage of cells in metaphase (M), anaphase (A) and telophase (T) when 15 compared to vehicle control (H 2 O) samples, while an increase in the number of apoptotic cells was observed. This effect (increased number of apoptotic cells) was also observed in MCF-12A samples, however no significant perturbation of cell cycle dynamic was seen in the non-tumorigenic cell line (Fig. 4) . 1000 cells were counted per slide, and absolute counts were converted to percentages. For clarity of comparison, interphase cells are not shown. 
Fluorescence microscopy
Fluorescent triple-staining with Hoechst / acridine orange / propidium iodide showed a marked increase in acidic intracellular vacuoles in both the MCF-7 breast adenocarcinoma and MCF-12A non-carcinogenic cell lines in samples exposed to S. frutescens (increase in green acridine orange fluorescent intensity) (Fig. 5) . This increase in acidic intracellular vesicle formation in response to S. frutescens exposure is indicative of autophagy induction. (Fig. 6) . Data is shown in table 2. Cells with more than 2N genetic content were classified as abnormal. 
Discussion
S. frutescens extracts have shown promising antiproliferative activity in previous studies (Chinkwo, 2005; Stander et al., 2009; Tai et al., 2004) , and significant inroads are being made into understanding the effects of these extracts on cell physiology and whole organism physiology, with data from in vitro studies augmented by experiments conducted in mice, rats and humans (Kundua et al., 2005; Prevoo et al., 2004; Chadwick et al., 2007; Grandi et al., 2005) . Our study revealed that aqueous S. frutescens extracts affect the proliferation, morphology and cell cycle dynamics of both the MCF-7 breast adenocarcinoma and MCF-20 12A non carcinogenic breast epithelial cell lines to varying degrees in a time-and dose dependent manner. Evaluation of cellular proliferation by crystal violet staining identified 1mg/ml and 48 hours to be the optimal time and dose combination for a comparative study of the effects of S. frutescens exposure. When the signaling pathways involved in these two distinct, but interlinked processes are taken into account, it seems probable that the exposed cells are using autophagy induction as primarily a survival mechanism. When this fails, cells enter early apoptosis (4.68% increase in MCF-7, 0.72% increase in MCF-12A), and subsequent late apoptosis and necrosis, leading to the observed morphological characteristics.
These findings are in concurrence with previous studies which have demonstrated the cytostatic and cytotoxic effects of S. frutescens in cervical carcinoma, CHO Chinese hamster ovary cancer cells, DU-145 prostate cancer cells and MDA-MB-231 breast cancer cells (Chinkwo, 2005; Tai et al., 2004; Steenkamp and Gouws, 2006) . In addition, this study yielded a novel finding demonstrating the induction of autophagy in the MCF-7 and MCF-12A cell lines using aqueous S. frutescens extracts. However the previously observed 22 phosphatidylserine externalization when utilizing ethanolic extracts (Chinkwo, 2005; Stander et al., 2009 ) was observed to a much lesser extent in the current study. This finding could indicate the ethanolic fractionalization of a key effector molecule leading to the promising cancer specific cytotoxic effects previously observed. Furthermore, no S-phase cell cycle arrest was observed in this study (previously reported in studies using ethanolic extracts of S.
frutescens) (Stander et al., 2009) , and the cancer specific cytotoxic effects previously reported in ethanolic extracts appear to be less pronounced when aqueous extracts are utilized. The carcinogenic MCF-7 cell line was, however, clearly more susceptible to the cytostatic effects described.
When taking into account the fact that a single pharmacologically active ingredient responsible for the varied effects of S. frutescens has not been isolated and the differing efficacy of ethanolic and aqueous extracts, it becomes apparent that the cumulative combination of the bioactive compounds in plant extracts (Shaik et al., 2010 ) must be responsible for the promising antiproliferative effects. The concentrations of each of the potentially therapeutic compounds is, to a large extent, dependent on the location (regional differences) and growth conditions (soil conditions, UV exposure etc.) of the individual plant (Moshe et al., 1998) . Further complicating the matter is the question of the taxonomic classification of S. frutescens into various subspecies (Moshe et al., 1998; Phillips and Dyer, 1934; Goldblatt and Manning, 2000) , and the part of the plant (e.g. leaves, stems etc.) from which the extract is derived (Shaik et al., 2010) . At this time, no single molecular pathway explaining the effects observed in studies investigating the therapeutic potential of S.
frutescens seems clear, with several distinct but interlinked mechanisms being the probable answer.
Conclusions
This study has broadened the understanding of the previously documented effects of S.
frutescens extracts by demonstrating that aqueous extracts have a differential influences on proliferation, morphology and cell death in the carcinogenic MCF-7 breast adenocarcinoma cell line when compared to the non-carcinogenic MCF-12A cell line. Due to the lack of a single, clearly elucidated biochemical pathway to account for the observed effects, further in vitro research and biochemical analyses regarding the physiological and molecular mechanisms of this potentially useful and cost-effective natural product are warranted.
